(Q27664223)

English

Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases

scientific article

Statements

Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases (English)
0 references
Chunjian Liu
0 references
James Lin
0 references
Stephen T Wrobleski
0 references
Shuqun Lin
0 references
John Hynes
0 references
Hong Wu
0 references
Alaric J Dyckman
0 references
Tianle Li
0 references
John Wityak
0 references
Kathleen M Gillooly
0 references
Sidney Pitt
0 references
Ding Ren Shen
0 references
Rosemary F Zhang
0 references
Kim W McIntyre
0 references
Luisa Salter-Cid
0 references
David J Shuster
0 references
Hongjian Zhang
0 references
Punit H Marathe
0 references
Arthur M Doweyko
0 references
John S Sack
0 references
Susan E Kiefer
0 references
Kevin F Kish
0 references
John A Newitt
0 references
Murray McKinnon
0 references
John H Dodd
0 references
Joel C Barrish
0 references
Gary L Schieven
0 references
Katerina Leftheris
0 references
23 September 2010
0 references
53
0 references
18
0 references
6629-39
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit